OPRX
OPTIMIZERX (OPRX)
NASDAQ
$4.97-$0.32 (-5.97%)
Price as of Jun 03, 2026 4:10 PM EDT
  • $97.4M
    Market Cap
  • -60.06%
    1-Year Change
  • Health Information Services
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 19
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network

OptimizeRx Corp. announced four new partner agreements expanding its point-of-care network, increasing National Provider Identifier (NPI) reach by 37% through exclusive partnerships with e-prescribing platforms and health systems access partners.

12/17/2025, 4:30 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$5.18
$5.46
$5.28
1-Year Range
$4.83
$21.68
$5.28
Latest Close$5.28
Change
-$0.10 (-1.89%)
Volume341,564
Market Cap$97.4M
Shares Outstanding18.8M
P/E (TTM)14.48
Diluted EPS (TTM)$0.36
Enterprise Value$100.6M

Information as of 06/02/2026

Company Profile

$97.4M
Market Cap
$6.8M
Net Income
Sector: Healthcare
Industry: Health Information Services
260 Charles Street, Waltham, MA, United States, 02453
248 651 6568

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Key Executives

  • Stephen L. Silvestro
  • Edward Stelmakh
  • Theresa Greco
  • Marion Odence-Ford
  • Heather Favazza

Current Ownership Distribution

  • Institutions243.4M (75.63%)
  • Mutual Funds67.8M (21.06%)
  • Insiders10.7M (3.31%)
  • Other0 (0.00%)